No Data
No Data
No Data
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Insider Sale: CEO & President of $SPRO Sells 106,408 Shares
The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts
H.C. Wainwright Maintains Spero Therapeutics(SPRO.US) With Buy Rating, Maintains Target Price $5
Express News | HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target
Optimistic Buy Rating for Spero Therapeutics Amid Strategic Initiatives and Partnerships
Unlock the Full List